Waters H, Goyal R, Strouss L, Legacy S, Nagar S, Wilbanks J. Regional differences in HEDIS measure results for schizophrenia treatment adherence in state Medicaid programs. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 19, 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S62.
Stanford RH, Nagar S, Lin X, O'Connor RD. Use of ICS/LABA on asthma exacerbation risk in patients within a medical group. J Manag Care Pharm. 2015 Nov;21(11):1014-9.
Hogue S, Hollis K, Silvia S, Wooddell M, White MV. Staff training and use of epinephrine auto-injectors for the treatment of anaphylaxis: results from the EPIPEN4SCHOOLS survey. Poster presented at the 2015 AMCP Nexus; October 27, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10a):s7.
Mladsi D, Ramamohan V, Ronquest N, Boklage SH. A cost-consequences analysis of inpatient tolvaptan compared with fluid restriction among SIADH patients with hyponatremia. Poster presented at the 2015 AMCP Nexus; October 26, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10-a):S33.
Ramamohan V, Mladsi D, Ronquest N, Boklage S. A cost-consequences analysis of inpatient tolvaptan compared with fluid restriction among CHF patients with hyponatremia. Poster presented at the 2015 AMCP Nexus; October 26, 2015. Orlando, FL. [abstract] J Manag Care Pharm. 2015 Oct; 21(10-a):S53.
Dalal AA, Patel JP, D'Souza A, Farrelly E, Nagar S, Shah M. Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Pharm. 2015 Jul;21(7):575-83.
Korsnes JS, Davis KL, Ariely R, Bell C, Mitra D. Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events. J Manag Care Pharm. 2015 Jun;21(6):443-50.
DaCosta Byfield S, McPheeters JT, Burton T, Nagar SP, Hackshaw MD. Persistence and compliance among US patients receiving pazopanib or sunitinib as first-line therapy for advanced renal cell carcinoma. J Manag Care Pharm. 2015 Jun;21(6):515-22.
Maglinte G, Graham C, Schwartzberg L, Price T, Knox H, Hechmati G, Hjelmgren J, Barber B, Fakih M. Economic analysis of panitumumab versus cetuximab in chemorefractory patients with wild-type KRAS metastatic colorectal cancer. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 9, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 21(4a):S11-2.
Wilson M, Mody R, Ursan I, Carr S. The budgetary impact of vedolizumab in the management of moderately to severely active ulcerative colitis and Crohn's disease in the United States. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 7, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 21(4a):S57.
Patel J, Coleman A, Wilson M, McDade C, Carr S, Earnshaw S. Budgetary impact on a U.S. health plan after adopting umeclidinium/vilanterol (UMEC/VI) for the management of moderate-to-severe COPD. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 7, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr 7; 21(4a):S55.
Wang T, Meyers J, Davis K, Madhwani S, Boklage S. Patterns of H. pylori treatment and testing for patients in a commercially insured population. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 1, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr; 21(4-a):S11.
Talbird SE, Graham JB, Mauskopf JA, Masseria C, Krishnarajah G. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases. J Manag Care Pharm. 2015 Jan;21(1):88-99.
Hansen RN, Hackshaw MD, Nagar SP, Arondekar B, Deen KC, Sullivan SD, Ramsey SD. Health care costs among renal cancer patients using pazopanib and sunitinib. J Manag Care Pharm. 2015 Jan;21(1):37-44.
Hackshaw MD, Nagar SP, Parks DC, Miller LA. Persistence and compliance with Pazopanib in patients with advanced renal cell carcinoma within a U.S. administrative claims database. J Manag Care Pharm. 2014 Jun;20(6):603-10.
Sharp L, Carsin AE, Cantwell MM, Anderson LA, Murray LJ. Intakes of dietary folate and other B vitamins are associated with risks of esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis. J Nutr. 2013 Dec;143(12):1966-73. doi: 10.3945/jn.113.174664
Brown TM, Siu K, Walker D, Pladevall-Vila M, Sander S, Mordin M. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation. J Manag Care Pharm. 2012 Jun 1;18(5):351-62.
Bell C, Graham JB, Earnshaw S, Oleen-Burkey MK, Castelli-Haley J, Johnson K. Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical data. J Manag Care Pharm. 2007 Apr 1;13(3):245-61.
Adams MR, Golden DL, Franke AA, Potter SM, Smith HS, Anthony MS. Dietary soy beta-conglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr. 2004 Mar;134(3):511-6.
Adams MR, Golden DL, Franke AA, Potter SM, Smith HS, Anthony MS. Inhibitory effects of dietary 7S globulin on atherosclerosis in mice exceed those of whole soy protein isolate and are independent of LDL receptors and plasma lipoproteins. J Nutr. 2004;134:1273S.
Zhang L, Anthony MS, Rowe P, Wagner J. Soy protein with isoflavones and isoflavone extract decrease oxidative stress via decreased reactive nitrogen species. J Nutr. 2004;134:1266S.
Appt SE, Clarkson TB, Anthony MS, St Clair RW. Complementary soy therapy prevents dyslipoproteinemia associated with tibolone treatment of postmenopausal cynomolgus monkeys. J Nutr. 2004;134:1274.
Anthony MS, Franke AA, Adams MR, Kaplan JR, Clarkson TB. Gender differences in isoflavone metabolism in nonhuman primates. J Nutr. 2004;134:1284S.
Register TC, Kaplan JR, Adams MR, Anthony MS, Williams JK, Blair RM. Soy isoflavone consumption is associated with serum soluble vascular cell adhesion molecule-1 (sVCAM-1) in postmenopausal monkeys. J Nutr. 2004;134:1244S.
Ackerman SJ, Mordin M, Reblando J, Xu X, Schein J, Vallow S, Brennan M. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain. J Manag Care Pharm. 2003 May 1;9(3):223-31.
Blair RM, Appt SE, Bennetau-Pelissero C, Clarkson TB, Anthony MS, Lamothe V, Potter SM. Dietary soy and soy isoflavones have gender-specific effects on plasma lipids and isoflavones in golden Syrian f(1)b hybrid hamsters. J Nutr. 2002 Dec;132(12):3585-91.
Mendez MA, Anthony MS, Arab L. Soy-based formulae and infant growth and development: a review. J Nutr. 2002 Aug;132(8):2127-30.
Vitolins MZ, Anthony MS, Lenchik L, Bland DR, Burke GL. Does soy protein and its isoflavones prevent bone loss in peri- and post-menopausal women? Results of a two-year randomized clinical trial. J Nutr. 2002;132:582S.
Clarkson TB, Anthony MS, Smith M, Wilson L, Barnes S. A paradoxical association between plasma isoflavone concentrations on a soy-containing diet, and both plasma lipoproteins and atherosclerosis. J Nutr. 2002;132:583S-4S.
Adams MR, Golden DL, Anthony MS, Williams JK. Inhibitory effects of soy protein isolate on atherosclerosis in mice do not require the presence of LDL receptors or effects on plasma lipoproteins. J Nutr. 2002;132:602S.
Adams MR, Golden DL, Anthony MS, Register TC, Williams JK. The inhibitory effect of soy protein isolate on atherosclerosis in mice does not require the presence of LDL receptors or modification of plasma lipoproteins. J Nutr. 2002 Jan;132(1):43-9.
Kaplan JR, Anthony MS, Clarkson TB. The antiatherogenic effects of soy phytoestrogens in relation to early and late lesion development. J Nutr. 2002;132:606S.
Anthony MS, Blair RM, Clarkson TB. Neither isoflavones nor the alcohol-extracted fraction added to alcohol-washed soy protein isolate restores the lipoprotein effects of soy protein isolate. J Nutr. 2002;132:583S.
Burke GL, Legault C, Anthony MS, Bland DR, Morgan TM, Naughton MJ. Soy protein and isoflavone effects on vasomotor symptoms in peri- and post-menopausal women: the soy estrogen alternative study. J Nutr. 2002;132:600S.
Pan YL, Anthony MS, Kapps M, Clarkson TB. A comparison of the effect of treatment with oral micronized estradiol or phytoestrogen-containing soy protein isolate on tail skin temperatures of ovariectomized rats. Poster presented at the 2000 American Society for Nutritional Sciences Conference; March 2000. [abstract] J Nutr. 2000 Mar; 130(3):706S. doi: 10.1093/jn/130.3.680S
Anthony MS. Soy and cardiovascular disease: cholesterol lowering and beyond. J Nutr. 2000 Mar;130(3):662S-3S.
Cline JM, Anthony MS, Mathes S, Clarkson TB. Effects of dietary soy on the uterus and breast of macaques. J Nutr. 2000;130:669S.
Pan YL, Anthony MS, Clarkson TB. Soy, estradiol, and cognitive function: effects on biomarkers and learning/memory performance of estrogen-deficient rats. J Nutr. 2000;130:677S.
Anthony MS, Clarkson TB, Hughes CLJr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 1996 Jan;126(1):43-50.
Anthony MS, Clarkson TB, Weddle DL, Wolfe MS. Effects of soy protein phytoestrogens on cardiovascular risk. J Nutr. 1995 Mar;125(Suppl 3):803S-4S.